Showing 32,021 - 32,040 results of 32,326 for search 'efficiency analysis three', query time: 0.41s Refine Results
  1. 32021
  2. 32022
  3. 32023
  4. 32024
  5. 32025
  6. 32026
  7. 32027
  8. 32028
  9. 32029
  10. 32030
  11. 32031
  12. 32032
  13. 32033
  14. 32034
  15. 32035

    Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy by Wen-Jing Yu, Jun Kong, Feng-Mei Zheng, Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yuan-Yuan Zhang, Yu-Qian Sun, Jian Jin, Xiao-Jun Huang, Yu Wang

    Published 2024-12-01
    “…The incidences of grades 3–4 neutropenia, anemia, and thrombocytopenia independently of pretreatment status were 30%, 20% and 20%, respectively.Conclusion: Venetoclax-based regimens are efficient and safe for MRD in patients with myeloid malignancies ineligible for or failed in the first-line immunotherapies after allo-HSCT.…”
    Get full text
    Article
  16. 32036
  17. 32037

    Retrospective antimicrobial consumption surveillance at health facility level in Dodoma Region, Tanzania by Karin Wiedenmayer, Samuel Mungai, Romuald Mbwasi, Calvin Andeve Omolo, Eva Ombaka, Rajabu Mohamedi Kingo

    Published 2025-05-01
    “…This study presents a robust method for monitoring AMC and resistance in a resource-efficient manner, offering potential applicability in similar settings across SSA. …”
    Get full text
    Article
  18. 32038

    Optimizing the Postcataract Patient Journey Using AI-Driven Teleconsultation: Prospective Case Study by Joukje C Wanten, Noël J C Bauer, Mohita Chowdhury, Aisling Higham, Nick de Pennington, Frank J H M van den Biggelaar, Rudy M M A Nuijts

    Published 2025-08-01
    “…Digital health technologies offer promising opportunities to efficiently manage high patient volumes. Cataract surgery, with its established safety profile and routine postoperative care, provides an ideal setting for implementing such innovations. …”
    Get full text
    Article
  19. 32039
  20. 32040

    PROFILE OF TRANSFUSION REACTIONS RELATED TO THE INFUSION OF HEMATOPOIETIC CELL IN A PEDIATRIC CENTER by ECDS Pirolli, RAF Tutumi, FW Garcia, R Nomura, ER Pinto, MJ Piloni, JLM Bach, C Bonfim

    Published 2024-10-01
    “…Method: A quantitative retrospective study with a cross-sectional design was conducted through medical record analysis. Patients aged between 0 and 18 years who underwent allogeneic HC at a pediatric center between January 2022 and December 2023 were included. …”
    Get full text
    Article